NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

I concur that the update was very ill conceived and could have been written much better. It left the company open to all the jabs now being made and inviting further shorting. But, it is the big picture that is important - this is going to MAA and approval very shortly. A few weeks more or a few weeks less is not going to make any difference to the longs. Not meeting our expectations is aggravating, but in the long run will not make one iota of difference. This is going to be the next SOC in this field and probably many other cancers. So sure, management deserves a bump on the head for handling the investor relations so very poorly, but i am confident that in the long run we will all be very happy despite the hiccups along the way.